Zobrazeno 1 - 10
of 11
pro vyhledávání: '"B. M. Logan"'
Autor:
U. Raghavan, B. M. Logan
Publikováno v:
The Journal of Laryngology & Otology. 114:456-459
The main cause of sinus pathology is disease in the middle meatus, therefore, unless nasal drops are deposited in this site they will not be effective. Currently, one of three standard head positions are used by patients for the instillation of nasal
Autor:
B. M. Logan, M.W. Yung
Publikováno v:
Clinical Otolaryngology and Allied Sciences. 24:262-265
The position, dimension and thickness of the exposed lacrimal bone at the lateral nasal wall in 10 cadaveric half-heads were examined. In all cases, the lacrimal bone at the lateral nasal wall was found to be just anterior to the mid-third of the unc
Publikováno v:
Revue de laryngologie - otologie - rhinologie. 121(1)
Dacryocystorhinostomy is the surgical treatment for nasolacrimal blockage. In recent years, the endoscopic approach has become more popular due to the development of nasal endoscopes and the ease of surgery in comparison to the external approach. In
Publikováno v:
Clinical anatomy (New York, N.Y.). 9(6)
In bilateral dissections of 68 cadavers, four examples were found unilaterally of variant slips of iliacus and psoas major muscles. In three of them the femoral nerve was pierced by the variant slip. One of these variants was a previously undocumente
Publikováno v:
Journal of Pharmaceutical Sciences. 73:471-477
A number of analogues of 3-dimethylamino-2-dimethylaminomethyl-1-(4-methoxyphenyl)-1-propanone dihydrochloride (IIa) and related compounds which showed activity against P388 lymphocytic leukemia were prepared, and of the 16 analogues, three met the c
Autor:
B. M. Logan, N.W. Hamon, Jonathan R. Dimmock, P. J. Smith, Krishnamurthy Shyam, S. K. Raghavan, D. J. Harwood
Publikováno v:
Journal of Pharmaceutical Sciences. 72:887-894
Series of 3-dimethylamino-1-aryl-1-propanone hydrobromides (IV) and 3-dimethylamino-2-dimethylaminomethyl-1-aryl-1-propanone dihydrobromides (V) were synthesized. Evaluation of these derivatives against P-388 lymphocytic leukemia growth revealed that
Publikováno v:
Journal of pharmaceutical sciences. 73(4)
A number of analogues of 3-dimethylamino-2-dimethylaminomethyl-1-(4-methoxyphenyl)-1-propanone dihydrochloride (IIa) and related compounds which showed activity against P388 lymphocytic leukemia were prepared, and of the 16 analogues, three met the c
Publikováno v:
Chemischer Informationsdienst. 15
Publikováno v:
Journal of public health policy. 6(4)
Autor:
Jonathan R. Dimmock, Krishnamurthy Shyam, N.W. Hamon, D. J. Harwood, P. J. Smith, S. K. Raghavan, B. M. Logan
Publikováno v:
Chemischer Informationsdienst. 15
□ Series of 3-dimethylamino-1-aryl-1-propanone hydrobromides (IV) and 3-dimethylamino-2-dimethylaminomethyl-1-aryl-1-propanone dihydrobromides (V) were synthesized. Evaluation of these derivatives against P-388 lymphocytic leukemia growth revealed